Signaling pathway involved in cyclooxygenase-2 up-regulation by hepatocyte growth factor in endometrial cancer cells

Oncology Reports

Volumn 26, Issue 4, 2011, Pages 957-964

  Yoshizawa, Yoriko ^a   Yamada, Yoshihiko ^a   Kanayama, Seiji ^a   Shigetomi, Hiroshi ^a   Kawaguchi, Ryuji ^a   Yoshida, Shozo ^a   Nagai, Akira ^a   Furukawa, Naoto ^a   Oi, Hidekazu ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anoikis; Cyclooxygenase 2; Endometrial cancer; Hepatocyte growth factor; Invasion; Migration

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANOIKIS; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANOIKIS; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; I-KAPPA B PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79960775048     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1348     Document Type: Article

References (52)

1. Nakamura T, Nawa K and Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450-1459, 1984. (Pubitemid 14073577)
2. Nakamura T, Nishizawa T, Hagiya M, et al: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989. (Pubitemid 19277521)
3. Funakoshi H and Nakamura T: Hepatocyte growth factor from diagnosis to clinical applications. Clin Chim Acta 327: 1-23, 2003. (Pubitemid 35447813)
4. Otte JM, Schmitz F, Kiehne K, Stechele HU, Banasiewicz T, Krokowicz P, Nakamura T, Folsch UR and Herzig K: Functional expression of HGF and its receptor in human colorectal cancer. Digestion 61: 237-246, 2000. (Pubitemid 30418224)
5. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM and Di Renzo MF: Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer 69: 212-217, 1996. (Pubitemid 26233301)
6. Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC and Van Waes C: Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 61: 5911-5918, 2001. (Pubitemid 32769111)
7. Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG, Comoglio PM and Di Renzo MF: Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small cell lung carcinomas. Br J Cancer 74: 1862-1868, 1996. (Pubitemid 27007128)
8. Kiehne K, Herzig KH and Fölsch UR: c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth. Pancreas 15: 35-40, 1997. (Pubitemid 27527357)
9. Wagatsuma S, Konno R, Sato S and Yajima A: Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82: 520-530, 1998. (Pubitemid 28112991)
10. Miyata Y, Kanetake H and Kanda S: Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma. Clin Cancer Res 12: 4876-4881, 2006. (Pubitemid 44338574)
11. Ren Y, Cao B, Law S, et al: Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 11: 6190-6197, 2005. (Pubitemid 41262947)
12. Worden B, Yang XP, Lee TL, et al: Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Cancer Res 65: 7071-7080, 2005. (Pubitemid 41161234)
13. Gao M, Fan S, Goldberg ID, Laterra J, Kitsis RN and Rosen EM: Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells. J Biol Chem 276: 47257-47265, 2001.
14. Bae-Jump V, Segreti EM, Vandermolen D and Kauma S: Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro. Gynecol Oncol 73: 265-272, 1999. (Pubitemid 29215742)
15. Yoshida S, Harada T, Iwabe T, et al: Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer. J Clin Endocrinol Metab 87: 2376-2383, 2002. (Pubitemid 34521533)
16. Park YH, Ryu HS, Choi DS, Chang KH, Park DW and Min CK: Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int J Gynecol Cancer 13: 53-60, 2003.
17. Tanaka T, Mizuno K, Umesaki N and Ogita S: Suppressed apoptotic susceptibility in human endometrial epithelial cells pretreated with hepatocyte growth factor. Clin Exp Obstet Gynecol 25: 125-128, 1998. (Pubitemid 29008269)
18. Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D and Wang CY: Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B. J Biol Chem 277: 25203-25208, 2002. (Pubitemid 34951827)
19. Graziani A, Gramaglia D, Cantley LC and Comoglio PM: The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J Biol Chem 266: 22087-22090, 1991. (Pubitemid 21908617)
20. Bowers DC, Fan S, Walter KA, Abounader R, Williams JA, Rosen EM and Laterra J: Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res 60: 4277-4283, 2000. (Pubitemid 30636617)
21. Day RM, Cioce V, Breckenridge D, Castagnino P and Bottaro DP: Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Oncogene 18: 3399-3406, 1999. (Pubitemid 29286986)
22. Smith WL: Prostanoid biosynthesis and mechanisms of action. Am J Physiol 263: 181-191, 1992.
23. Nzeako UC, Guicciardi ME, Yoon JH, Bronk SF and Gores GJ: COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells. Hepatology 35: 552-559, 2002. (Pubitemid 34183958)
24. Tang X, Sun YJ, Half E, Kuo MT and Sinicrope F: Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res 62: 4903-4908, 2002. (Pubitemid 34984412)
25. McFall A, Ulku A, Lambert QT, Kusa A, Rogers-Graham K and Der CJ: Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. Mol Cell Biol 21: 5488-5499, 2001. (Pubitemid 32702453)
26. Frisch SM: Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis. Curr Biol 23: 1047-1049, 1999.
27. You Z, Saims D, Chen S, et al: Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 157: 429-440, 2002. (Pubitemid 34839807)
28. Kanayama S, Yamada Y, Kawaguchi R, et al: Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells. Oncol Rep 19: 117-122, 2008. (Pubitemid 351176139)
29. Folkman J and Moscona A: Role of cell shape in growth control. Nature 273: 345-349, 1978. (Pubitemid 8344174)
30. Wu D, Marko M, Claycombe K, Paulson KE and Maydani SN: Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-kappa B activity. J Biol Chem 278: 10983-10992, 2003. (Pubitemid 36792646)
31. Yeo SJ, Gravis D, Yoon JG and Yi AK: Myeloid differentiation factor 88-dependent transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: role of NF-kappaB and p38. J Biol Chem 278: 22563-22573, 2003. (Pubitemid 36830312)
32. Hung JH, Su IJ, Lei HY, Wang HC, Lin WC, Chang WT, Huang W, Chang WC, Chang YS, Chen CC and Lai MD: Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem 279: 46384-46392, 2004. (Pubitemid 39518279)
33. Appleby SB, Ristimäki A, Neilson K, Narko K and Hla T: Structure of the human cyclo-oxygenase-2 gene. Biochem J 302: 723-727, 1994. (Pubitemid 24289307)
34. Barnes PJ and Karin M: Nuclear factor κB: A pivotal transcription factor in chronic inflammatory disease. N Engl J Med 336: 1066-1071, 1997. (Pubitemid 27163860)
35. Baeuerle PA and Baltimore D: NFκB: ten years after. Cell 87: 13-20, 1996.
36. Sasaki K, Sato M and Umezawa Y: Fluorescent indicators for Akt/ protein kinase B and dynamics of Akt activity visualized in living cells. J Biol Chem 278: 30945-30951, 2003. (Pubitemid 36994606)
37. Romanshkova JA and Makarov SS: NF-6B is a target of Akt in antiapoptotic PDGF signaling. Nature 401: 86-90, 1999.
38. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NFκB activity. Annu Rev Immunol 18: 621-663, 2000. (Pubitemid 30365393)
39. Perkins ND: Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007.
40. Nakao S, Ogtata Y, Shimizu E, Yamazaki M, Furuyama S and Sugiya H: Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Mol Cell Biochem 238: 11-18, 2002. (Pubitemid 35023524)
41. Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID and Rosen EM: Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24: 1749-1766, 2005. (Pubitemid 40461131)
42. Wang R, Wang X, Lin F, Gao P, Dong K and Zhang HZ: shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem 317: 179-188, 2008.
43. van Wijngaarden J, van Beek E, van Rossum G, van der BC, Hoekman K, van der PG, van der Pol MA, Broxterman HJ, van Hinsbergh VW and Lowik CW: Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation. Eur J Cancer 43: 433-442, 2007. (Pubitemid 46123984)
44. Abrahao AC, Castilho RM, Squarize CH, Molinolo AA, dos Santos-Pinto D Jr and Gutkind JS: A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation. Oral Oncol 46: 880-887, 2010.
45. Grotegut S, von Schweinitz D, Christofori G and Lehembre F: Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 25: 3534-3545, 2006. (Pubitemid 44264864)
46. Gumbiner BM: Regulation of cadherin adhesive activity. J Cell Biol 148: 399-404, 2000.
47. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
48. Cavallaro U and Christofori G: Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132, 2004. (Pubitemid 38198740)
49. Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166, 2002.
50. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005. (Pubitemid 41267170)
51. Barrallo-Gimeno A and Nieto MA: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132: 3151-3161, 2005. (Pubitemid 41167144)
52. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83, 2000.